文献速递免疫规划妇幼与学校卫生

伊朗临近结婚女性抗风疹和抗麻疹抗体血清流行率调查

Seroprevalence of anti-rubella and anti-measles antibodies in women at the verge of marriage in Iran.
PubMed 文献 · Vaccine · 2019-10-24

为评估未来母亲对风疹和麻疹的血清免疫水平,在伊朗31个省中随机抽取10个省、40个婚前咨询中心,采用多阶段抽样对1600名临近结婚女性进行访谈和采血,用ELISA法检测抗风疹和抗麻疹IgG抗体。结果显示抗风疹抗体总血清流行率为90.6%(95%CI:89.1至92.0%),抗麻疹为80.7%(95%CI:78.7至82.6%);2003年免疫运动对5至25岁人群的效果14年后仍明显,18岁以上女性两种抗体血清流行率均更高。

要点

  • 抗风疹和抗麻疹抗体总血清流行率分别为90.6%(95%CI:89.1至92.0%)和80.7%(95%CI:78.7至82.6%)。
  • 2003年免疫运动对5至25岁人群的效果14年后仍明显,18岁以上女性两种抗体血清流行率均更高。
  • 作者认为可考虑实施补充免疫活动或修订国家免疫规划在青少年期增加第三剂含麻疹和风疹疫苗。

核心结论

  • 伊朗临近结婚女性抗风疹和抗麻疹抗体总血清流行率分别为90.6%(95%CI:89.1至92.0%)和80.7%(95%CI:78.7至82.6%)。
  • 2003年针对风疹和麻疹的免疫运动对5至25岁人群的效果14年后仍明显,18岁以上女性两种抗体血清流行率均高于较年轻年龄组。
  • 作者认为可考虑实施补充免疫活动或修订国家免疫规划在青少年期增加第三剂含麻疹和风疹疫苗,以弥合较年轻年龄组的血清免疫差距。

研究设计与样本

  • 在伊朗31个省中随机抽取10个省,采用多阶段抽样方法,在40个区的40个婚前咨询中心对1600名参与者进行访谈和采血。
  • 采用ELISA法在伊朗德黑兰医科大学公共卫生学院国家麻疹和风疹参考实验室检测血清抗风疹和抗麻疹IgG抗体。
  • 1600名初始参与者中,1573名检测风疹、1569名检测麻疹。

主要发现

  • 抗风疹抗体总血清流行率为90.6%(95%CI:89.1至92.0%),抗麻疹抗体总血清流行率为80.7%(95%CI:78.7至82.6%)。
  • 2003年免疫运动对5至25岁人群的效果14年后仍明显,当前研究时年龄18岁以上者与较年轻年龄队列相比,抗麻疹和抗风疹抗体血清流行率均有 sharp 差异。
  • 两种疾病中,18岁以上女性检测到的抗体血清流行率均更高。

临床怎么用

  • 作者认为可考虑实施补充免疫活动或修订国家免疫规划在青少年期增加第三剂含麻疹和风疹疫苗,作为弥合较年轻年龄组血清免疫差距的可能选项。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Measles and rubella as two highly contagious eruptive diseases are on the agenda to be eliminated in Iran by 2020. To evaluate the seroimmunity of the future mothers against rubella and measles, a nationwide serosurvey was implemented in 10 provinces, selected at random from 31 provinces in the country. METHODS: using a multistage sampling method, 1600 participants were interviewed and blood sampled in 40 'Pre-marriage Consultation Centers' across 40 districts. Using ELISA method, the sera were tested for anti-rubella and anti-measles IgG antibodies in the National Reference Laboratory for Measles and Rubella, School of Public Health, Tehran University of Medical Sciences, Tehran, Iran. RESULTS: Of the 1600 initial participants, the sera of 1573 participants were tested for rubella and 1569 for measles. The total seroprevalence of anti-rubella and anti-measles antibodies were 90.6% (95%CI: 89.1 to 92.0%) and 80.7% (95%CI: 78.7 to 82.6%) respectively. After 14 years, the effect of the immunization campaign of 2003 against rubella and measles on the age group of 5 to 25 years, was still apparent, i.e., there was a sharp difference between the seroprevalence of antibody (against both measles and rubella) of those who at the time of the present study were above 18 years with the younger age cohorts. For both diseases, higher seroprevalence of antibodies was detected in women above 18 years old. CONCLUSION: Implementation of a Supplemental Immunization activity or revision of the national immunization schedule to add a third dose of measles and rubella containing vaccine during adolescence are/might be considered as possible options for bridging the gap in the seroimmunity of the younger age groups.

来源:Vaccine,查看原文。版权归原作者所有。

引用

  1. Zahraei SM, Mokhtari-Azad T, Izadi S, et al. Seroprevalence of anti-rubella and anti-measles antibodies in women at the verge of marriage in Iran. Vaccine. 2019. PMID: 31668816. doi:10.1016/j.vaccine.2019.10.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。